Cargando…

A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma

BACKGROUND: Patients with metastatic renal cell carcinoma (mRCC) have variable survival outcomes. When discussing management approaches and providing information to patients and caregivers, it is important to have realistic perspectives, especially if the expected prognosis is very unfavorable. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syed, Mohsan Ali, Nieder, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330770/ https://www.ncbi.nlm.nih.gov/pubmed/28270887 http://dx.doi.org/10.14740/jocmr2839w

Ejemplares similares

The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patients
por: Yin, Zhenzhen, et al.
Publicado: (2017)

Survival Effects of Radiotherapy on Patients Newly Diagnosed with Distant Metastatic Nasopharyngeal Carcinoma in Non-High-Incidence Areas
por: Yang, Yongqiang, et al.
Publicado: (2021)

Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome
por: Nieder, Carsten, et al.
Publicado: (2020)

Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram?
por: Nieder, Carsten, et al.
Publicado: (2017)

Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
por: Nieder, Carsten, et al.
Publicado: (2008)

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma
por: Li, Haoran, et al.
Publicado: (2023)

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
por: Gonsalves, W I, et al.
Publicado: (2015)

Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
por: Bello, Jibril Oyekunle
Publicado: (2017)

Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer
por: Hsu, Ju-Yi, et al.
Publicado: (2022)

Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer
por: Barbier, Michaela C., et al.
Publicado: (2022)

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
por: Nieder, Carsten, et al.
Publicado: (2015)

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
por: Nieder, Carsten, et al.
Publicado: (2020)

Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients
por: Chen, Xuduan, et al.
Publicado: (2020)

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
por: Straube, Christoph, et al.
Publicado: (2020)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
por: Barkan, Ella, et al.
Publicado: (2023)

Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
por: Chen, Viola J., et al.
Publicado: (2019)

Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanoma
por: Gullotti, David M, et al.
Publicado: (2022)

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2021)

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
por: Mynster Kronborg, Thit, et al.
Publicado: (2023)

A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
por: Alchahin, Adele M., et al.
Publicado: (2022)

Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2019)

Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy
por: Bhanegaonkar, Abhijeet, et al.
Publicado: (2021)

Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study
por: Zhang, Dongxiao, et al.
Publicado: (2018)

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
por: Tampellini, M., et al.
Publicado: (1997)

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit
por: Dimopoulos, M A, et al.
Publicado: (2017)

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
por: Yan, Ge, et al.
Publicado: (2022)

Metastatic renal cell carcinoma diagnosed by capsule endoscopy and double balloon endoscopy
por: Takeda, Tsutomu, et al.
Publicado: (2011)

Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real-World Analysis in the SEER Database
por: Yang, Xiaojing, et al.
Publicado: (2020)

Preoperative Immune-Inflammatory Status of the Patients With Newly-Diagnosed Glioblastoma – Could It Genuinely Predict Their Survival?
por: Serban, Georgiana M, et al.
Publicado: (2023)

Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial
por: Trivedi, Anuradha G., et al.
Publicado: (2023)

Short overview on the current standard of treatment in newly diagnosed multiple myeloma
por: Willenbacher, Ella, et al.
Publicado: (2018)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
por: Buda-Nowak, Anna, et al.
Publicado: (2017)

Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma
por: Zheng, Wenwen, et al.
Publicado: (2020)

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
por: Wu, Kan, et al.
Publicado: (2020)

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
por: Jürgens, Hannes, et al.
Publicado: (2020)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ob7k88772uv7mm3f5fomf6jsbl